Back
Compare AU
Compare TBIL vs. HLTH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck 1-3 Month Us Treasury Bond ETF (TBIL) and the VanEck Global Healthcare Leaders ETF (HLTH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
TBIL | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 5 | 57 |
Median incremental investment | $994.46 | $550.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,703.10 | $1,423.52 |
Average age group | > 35 | > 35 |
Key Summary
TBIL | HLTH | |
|---|---|---|
Strategy | TBIL.AX was created on 2023-05-16 by VanEck. The fund's investment portfolio concentrates primarily on investment grade fixed income. The ETF currently has 103.25m in AUM and 19 holdings. TBIL.AX invests in a portfolio of US dollar denominated Treasury Bills issued by the US Government with a maturity ranging from 1-3 months with the aim of providing investment returns (before fees and costs) that closely track the returns of the Index | HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 49.59m in AUM and 51 holdings. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars. |
Top 3 holdings | United States Treasury Bills (11.98 %) United States Treasury Bills (9.93 %) United States Treasury Bills (8.22 %) | Arrowhead Pharmaceuticals Inc (3.01 %) West Pharmaceutical Services Inc (2.82 %) Illumina Inc (2.75 %) |
Top 3 industries | Health Care (100.00 %) Other (9.10 %) | |
Top 3 countries | United States (65.74 %) Japan (10.95 %) Denmark (8.04 %) | |
Management fee | 0.22 % | 0.45 % |
Key Summary
TBIL | HLTH | |
|---|---|---|
Issuer | VanEck | VanEck |
Tracking index | Bloomberg 1-3 Month U.S. Treasury Bill Index - Benchmark TR Gross | MarketGrader Developed Markets ex-Australia Health Care Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.22 % | 0.45 % |
Price | $48.66 | $11.48 |
Size | $102.964 million | $49.068 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 3.18 % | 0.51 % |
Market | ASX | ASX |
First listed date | 17/05/2023 | 09/09/2020 |
Purchase fee | $6.50 | $6.50 |
Community Stats
TBIL | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 5 | 57 |
Median incremental investment | $994.46 | $550.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,703.10 | $1,423.52 |
Average age group | > 35 | > 35 |
Pros and Cons
TBIL | HLTH | |
|---|---|---|
Pros |
|
|
Cons |
|
|
TBIL | HLTH |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |